2019
Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)
Bellon JR, Guo H, Barry WT, Dang CT, Yardley DA, Moy B, Marcom PK, Albain KS, Rugo HS, Ellis M, Wolff AC, Carey LA, Overmoyer BA, Partridge AH, Hudis CA, Krop I, Burstein HJ, Winer EP, Tolaney SM. Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial). Breast Cancer Research And Treatment 2019, 176: 303-310. PMID: 31004299, DOI: 10.1007/s10549-019-05238-4.Peer-Reviewed Original ResearchConceptsHER2-positive breast cancerLocal-regional recurrenceDisease-free survivalEffective anti-HER2 therapyLRR-free survivalAnti-HER2 therapyBreast-conserving surgeryBreast cancerRadiation therapySystemic therapyHormone receptor-positive tumorsProspective multi-institutional studyHER2-negative diseaseHER2-positive diseaseNegative axillary nodesEffective systemic therapyProspective multicenter trialEarly-stage patientsKaplan-Meier methodReceptor-positive tumorsHER2-positive tumorsMulti-institutional studyFuture investigational effortsAdjuvant trastuzumabProtocol therapy
2003
Follow-up care of breast cancer survivors
Partridge AH, Winer EP, Burstein HJ. Follow-up care of breast cancer survivors. Seminars In Oncology 2003, 30: 817-825. PMID: 14663782, DOI: 10.1053/j.seminoncol.2003.08.026.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsBreast cancerCancer survivorsPossible long-term complicationsSecond primary breast cancerComplications of therapyPrimary breast cancerLong-term complicationsLocal-regional recurrenceSymptoms of recurrenceBreast cancer treatmentPatient-clinician relationshipMetastatic diseaseContralateral breastPsychosocial concernsPsychosocial supportAdequate surveillanceCancer treatmentCancerComplicationsPatientsPersonal historyRecurrenceTherapySurvivors